Shares of Aurora Cannabis Inc (NYSE:ACB) have been assigned an average rating of “Buy” from the nine research firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $10.04.
A number of equities analysts have weighed in on ACB shares. Jefferies Financial Group started coverage on shares of Aurora Cannabis in a research report on Monday, February 25th. They set a “buy” rating for the company. ValuEngine upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Tuesday, March 19th. GMP Securities upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Wednesday, March 13th. Desjardins assumed coverage on shares of Aurora Cannabis in a report on Thursday, April 25th. They issued a “buy” rating and a $9.07 price target on the stock. Finally, Bank of America assumed coverage on shares of Aurora Cannabis in a report on Wednesday, April 17th. They issued a “buy” rating and a $11.00 price target on the stock.
Several institutional investors have recently made changes to their positions in the company. Morgan Stanley lifted its holdings in shares of Aurora Cannabis by 30.8% in the first quarter. Morgan Stanley now owns 11,804,752 shares of the company’s stock worth $106,951,000 after buying an additional 2,776,706 shares in the last quarter. ETF Managers Group LLC purchased a new stake in shares of Aurora Cannabis in the fourth quarter worth about $40,454,000. AQR Capital Management LLC lifted its holdings in shares of Aurora Cannabis by 39.2% in the first quarter. AQR Capital Management LLC now owns 7,102,892 shares of the company’s stock worth $64,268,000 after buying an additional 1,999,645 shares in the last quarter. Norges Bank purchased a new stake in shares of Aurora Cannabis in the fourth quarter worth about $30,915,000. Finally, TD Asset Management Inc. purchased a new stake in shares of Aurora Cannabis in the fourth quarter worth about $16,657,000. 8.09% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NYSE:ACB opened at $8.25 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.37 and a quick ratio of 1.98. The stock has a market cap of $8.37 billion, a price-to-earnings ratio of 68.75 and a beta of 2.82. Aurora Cannabis has a twelve month low of $4.05 and a twelve month high of $12.52.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Further Reading: How does equity income fit into an investing strategy?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.